#VisualAbstract: Addition of everolimus to letrozole improves survival in patients with HR⁺ breast cancer and disease progression on tamoxifen
Click to read this study in JAMA Oncology.
Tag: tamoxifen
#VisualAbstract: Extended letrozole therapy improves disease-free survival in postmenopausal patients with breast cancer
Click to read the study in The Lancet Oncology.
#VisualAbstract: Early discontinuation of endocrine therapy may increase risk of breast cancer recurrence in premenopausal women
Click to read the study in Clinical Cancer Research.
#VisualAbstract: Aromatase inhibitors superior to tamoxifen for progression-free survival in HR⁺ advanced breast cancer
Click to read the study in the European Journal of Cancer.
#VisualAbstract: Addition of palbociclib to adjuvant endocrine therapy does not improve survival in patients with HR⁺, HER2- breast cancer
Click to read the study in The Lancet Oncology.
#VisualAbstract: Endocrine therapy plus oral S-1 improves invasive disease-free survival in patients with ER⁺ breast cancer
Click to read the study in The Lancet Oncology.
#VisualAbstract: Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer
Most estrogen receptor (ER)-positive breast cancers can be classified as luminal A or luminal B subtype. It has been estimated ...
Quick Take: Assessment of long-term distant recurrence-free survival associated with tamoxifen therapy in post-menopausal patients with luminal A or luminal B breast cancer
Most estrogen receptor (ER)-positive breast cancers can be classified as luminal A or luminal B subtype. It has been estimated ...
Quick Take: Overall survival with ribociclib plus endocrine therapy in breast cancer
Hormone therapy is the standard of care for premenopausal and postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor2 ...
Anastrazole superior to tamoxifen for breast cancer treatment [Classics Series]
1. Postmenopausal women with advanced breast cancer randomized to anastrazole as first-line therapy experienced an increase in time to progression ...
Popular Reports
-
Automated pupillometry may be helpful in opioid agonist therapy dosing for opioid use disorder
-
Ultrasound features associated with shoulder complaints
-
#VisualAbstract: Adequate antibody response to mRNA-1273 COVID-19 vaccine occurs in patients with cancer
-
#VisualAbstract High cost of healthcare was the highest patient-reported barrier to accessing outpatient dermatologic care
-
Lowering systolic blood pressure with antihypertensives may reduce new-onset type 2 diabetes
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.